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CASE REPORT
17p11.2 and Xq28 duplication detected 
in a girl diagnosed with Potocki–Lupski 
syndrome
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Abstract 
Background: Potocki–Lupski syndrome is a microduplication syndrome associated with duplication at 17p11.2. 
Features include facial dysmorphism, moderate to mild cognitive impairment and behavioural abnormalities includ-
ing autism spectrum disorders.
Case presentation: We describe a patient from Sri Lanka that was referred for genetic assessment at 4 years of age 
due to subtle facial dysmorphism and expressive language impairment. She was diagnosed with Potocki–Lupski syn-
drome through multiplex ligation probe amplification. She carried two duplications; one in 17p11.2 consistent with 
Potocki–Lupski, and one in Xq including the region for X-linked intellectual disability.
Conclusion: Despite the absence of expected behavioural symptoms, many features of this patient are in accord-
ance with Potocki–Lupski syndrome. This is the first diagnosed patient in Sri Lanka.
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Background
Potocki–Lupski syndrome (PTLS) is associated with a 
microduplication of chromosome 17p11.2 [1]. The clini-
cal features of PTLS typically include infantile hypoto-
nia, poor feeding, failure to thrive, developmental delay, 
intellectual disability, speech and language impairment, 
behavioural abnormalities and autistic spectrum disorder 
[2]. The phenotypic spectrum in adults with PTLS has 
not been determined.
The genetic mechanism underlying PTLS has been 
recognised as Non Allelic Homologous Recombination 
(NAHR) at the 17p11.2 chromosomal region [3]. This 
region is known to be rich in low copy repeats which is 
a major cause for DNA rearrangements and associated 
genomic disorders.
Genetic diagnosis of PTLS has been based on chromo-
some banding, fluorescent in situ hybridisation, multiplex 
ligation probe amplification and recently genomewide 
microarray. This is the first case report describing the 
diagnosis of PTLS through the use of multiplex ligation 
probe amplification (MLPA) in Sri Lanka.
Case presentation
We report a 4  year old female with PTLS (OMIM 
610883) from Sri Lanka who was diagnosed with dupli-
cation 17p11.2 by multiplex ligation probe amplification 
performed due to severe expressive speech impairment. 
She was a product of non-consanguineous parents, born 
at 37 weeks gestation by lower segment caesarean section 
due to maternal gestational diabetes, with a birth weight 
of 2.885 kg. There was no history of infantile hypotonia. 
Developmental milestones were delayed with walking 
achieved at 2  years of age. Speech delay was noted and 
at presentation she was capable of speaking a maximum 
of two words together with inability to construct sen-
tences. Receptive language skills were not impaired. 
Hearing showed no clinically apparent deficit. Vision was 
impaired with hypermetropia, and she used spectacles. 
She was cheerful and engaged well socially. Common 
symptoms of autism including avoidance of eye contact, 
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repetitive behaviour, fixations and lack of interest in 
social interaction were not present. She had borderline 
to mild intellectual disability based on clinical evalua-
tion and was schooling with peers. There was no history 
of cardiac defects or sleeping problems. On examination 
she had distinctive facial features including triangular 
face, wide forehead, slightly downslanting palpebral fis-
sures, prominent tip of nose, smooth philtrum, and den-
tal malocclusion. Hands showed clinodactyly of the 5th 
finger bilaterally and an increased gap between the first 
and second toe of the right foot.
Methods
Genetic analysis was performed using multiplex ligation 
probe amplification (MLPA). The SALSA® MLPA® P245 
Microdeletion Syndromes-1 probemix (MRC Holland, 
Amsterdam, The Netherlands) that has been developed 
to screen patients presenting with unexplained devel-
opmental delay and/or mental retardation for multi-
ple microdeletion syndromes was used. This revealed a 
duplication of 17p11.2. The region included the retinoic 
acid inducible 1 gene (RAI1) gene which is compat-
ible with PTLS. Apart from the RAI1 gene leucine rich 
repeat containing 48 (LRRC48) and lethal giant larvae 
homolog 1 (LLGL1) genes in the 17p11.2 chromosomal 
region were duplicated. In addition the Xq28 chromo-
somal region which includes methyl CpG binding protein 
2 (MECP2) gene showed duplication (Fig. 1).
All procedures adhered to institutional guidelines (Eth-
ics Review Committee, Faculty of Medicine, University of 
Colombo) and to the Helsinki Declaration.
Discussion
This is the first report of PTLS diagnosis in Sri Lanka. 
Clinically the patient presented with speech impairment 
and mild facial dysmorphism. However unlike the major-
ity of previously reported cases of PTLS behavioural 
symptoms including autism spectrum disorders were 
not present. Genetic diagnosis of PTLS was made using 
MLPA, which showed 17p11.2 duplication. In addition 
she also carried duplication in the Xq28 chromosomal 
region.
Genetic disorder assessment previously limited to 
microscopic chromosomal anomalies and single nucleo-
tide polymorphisms (SNP) detected by traditional poly-
merase chain reaction (PCR) based sequencing has 
expanded following the detection of copy number vari-
ations (CNV). Many sporadic microdeletions, microdu-
plication syndromes have been recognised to occur due 
to CNV. Disease occurrence is either due to altered copy 
number of genes susceptible to dosage effect or changes 
in the regulatory sequences. Detection of such CNV 
requires locus specific testing either through fluorescent 
in situ hybridisation, multiplex ligation probe amplifica-
tion or high resolution screening of the entire genome 
through microarray technology. In resource limited 
Fig. 1 Multiplex ligation probe amplification output showing duplication at 17p11.2 and Xq28 regions
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settings such as Sri Lanka, MLPA techniques provide an 
opportunity to arrive at a genetic diagnosis. However, 
genome wide screening through microarray technology 
should be the next step in diagnostics.
The low copy repeats found in the proximal short arm 
of chromosome 17 region has been identified as a major 
cause of DNA rearrangements associated with many 
genomic disorders [1]. PTLS which is due to duplica-
tion 17p11.2, is associated with duplication of the reti-
noic acid inducible 1 gene (RAI1), which was seen in our 
patient [4]. The MLPA mix used in the microduplication, 
microdeletion testing included probes for 22 syndromes, 
including Smith Magenis syndrome (SMS). As the recip-
rocal microduplication syndrome of SMS, detection of 
PTLS was possible through RAI1 gene dosage. The phe-
notype of this patient was relatively mild and had the 
possibility of being unrecognized despite the varied med-
ical symptoms. Therefore referral for genetic evaluation 
in the presence of delay in global or selected milestones is 
useful to obtain an etiological diagnosis despite the limi-
tations in sensitivity and specificity of methods used at 
present.
MECP2 duplication syndrome is a condition that 
occurs almost exclusively in males and manifest as 
developmental delay, infantile hypotonia, absent speech 
and lack of ambulation [5]. This is thought to be due to 
skewed X chromosome inactivation with the resulting 
inactivation of the duplication containing X chromosome 
in females. Therefore despite similar clinical features in 
PTLS and MECP2 duplication syndromes, the clinical 
features noted in the patient were assumed to be asso-
ciated with PTLS syndrome. However recently females 
with MECP2 duplication have been found to manifest 
neurobehavioral and psychiatric symptoms [6]. There-
fore further investigation is ideal to confirm skewed X 
chromosome inactivation. The patient lacked signifi-
cant behavioural or psychiatric symptoms which are of 
additional significance to discount the clinical effect 
possibly caused by duplication of MECP2. However the 
dual duplication of the two chromosomal regions of the 
genome in this patient was interesting to note.
Conclusion
This case report describes the clinical features and 
genetic findings of a 4  year old girl diagnosed with 
Potocki–Lupski syndrome. Symptoms and signs are 
in accordance with reported clinical features of PTLS. 
Genetic diagnosis through MLPA has revealed duplica-
tions in 17p11.2 and Xq28. This includes the critical RAI1 
gene which has been shown to be associated with PTLS.
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